EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Development and external validation of an admission-based model for 180-day mortality in diabetic acute myocardial infarction

Yanlong Zhao, Haodong Jiang, Yuanyuan Zhao, Shuai Wang, Qicheng Yu, Jing Zeng, Shan Xie, Jiatong Li, Zhi Liu

Frontiers in Endocrinology · 02.07.2026 · 17

DOI: 10.3389/fendo.2026.1891663 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Frontiers in Endocrinology, online erschienen am 02.07.2026. Verfasst von Yanlong Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Diabetes Mellitus, Patient Admission. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with diabetes mellitus and acute myocardial infarction (DM-AMI) are at high risk, but risk heterogeneity within this subgroup remains insufficiently characterized. Whether a parsimonious admission-based model provides prognostic information beyond GRACE remains uncertain. We aimed to assess admission risk heterogeneity in DM-AMI and develop and externally validate a model for 180-day mortality using routine variables.

Methods

This retrospective dual-cohort study included AMI patients from a Beijing tertiary hospital (development cohort) and an ICU-based MIMIC-IV cohort (external validation). A Cox model was built using admission variables. Model performance was evaluated using discrimination, calibration, and decision curve analysis with internal bootstrap validation and comparison with GRACE.

Results

Among 4,167 patients, 1,514 had DM-AMI with 90 deaths at 180 days. The model included eight variables (age, heart rate, SBP, glucose, BUN, hemoglobin, RDW, WBC). It showed good discrimination in the development cohort (C-index 0.848; AUC 0.857) and maintained performance externally (AUC 0.744). GRACE comparison showed similar discrimination, while the combined model improved performance (ΔAUC = 0.014, P = 0.031). Calibration in MIMIC-IV indicated risk overestimation (slope 0.527; O/E 0.652).

Conclusion

DM-AMI patients exhibit marked admission risk heterogeneity. The model provides complementary prognostic information beyond GRACE but requires recalibration for absolute risk use in external settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionDiabetes MellitusPatient AdmissionHumansRetrospective StudiesFemalePrognosisMaleAgedMiddle AgedRisk AssessmentRisk Factors

Stichwörter der Autor:innen

acute myocardial infarctiondiabetes mellitusexternal validationmortality predictionprognostic modelrisk stratification

Autor:innen und Institutionen

  • Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Department of Medical Care, Beijing Luhe Hospital, Capital Medical University, Beijing, China.

Zitieren

APA

Zhao, Y., Jiang, H., Zhao, Y., Wang, S., Yu, Q., Zeng, J., Xie, S., Li, J., & Liu, Z. (2026). Development and external validation of an admission-based model for 180-day mortality in diabetic acute myocardial infarction. Frontiers in Endocrinology, 17. https://doi.org/10.3389/fendo.2026.1891663

Vancouver

Zhao Y, Jiang H, Zhao Y, Wang S, Yu Q, Zeng J, et al. Development and external validation of an admission-based model for 180-day mortality in diabetic acute myocardial infarction. Frontiers in Endocrinology. 2026;17. doi:10.3389/fendo.2026.1891663

BibTeX
@article{Zhao2026,
  author = {Zhao, Yanlong and Jiang, Haodong and Zhao, Yuanyuan and Wang, Shuai and Yu, Qicheng and Zeng, Jing and Xie, Shan and Li, Jiatong and Liu, Zhi},
  title = {Development and external validation of an admission-based model for 180-day mortality in diabetic acute myocardial infarction},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fendo.2026.1891663}
}
Kostenlos starten →